All About Alzheimer's Caring Conversations
For the first time, drugs targeting amyloid plaques have moved beyond trials and into real world use. Treatments like Kisunla and Leqembi, approved in 2023 and 2024, have helped validate the long debated amyloid theory.
13 afleveringen
Reacties
0Wees de eerste die een reactie plaatst
Meld je nu aan en word lid van de All About Alzheimer's Caring Conversations community!